Difference between revisions of "Burnett JP, et al. Cancer Lett. (2017) cited as Ref 302 in DOI: 10.1038/s41392-020-0110-5 (Q9565)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 394, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 52-64, #quickstatements; #temporary_batch_1590074839150) |
||
(One intermediate revision by the same user not shown) | |||
Property / title | |||
+ | Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells (English) | ||
Property / title: Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 52-64 | ||
Property / Page(s): 52-64 / rank | |||
+ | Normal rank |
Latest revision as of 15:37, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Burnett JP, et al. Cancer Lett. (2017) cited as Ref 302 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Burnett JP
0 references
2017
0 references
Cancer Lett.
0 references
394
0 references
Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells (English)
0 references
52-64
0 references